Cmed Reaches 20 Years of Zero Downtime for Clinical Database Services

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

HORSHAM, England and MORRISVILLE, N.C., Dec. 12, 2019 /PRNewswire/ — Cmed Technology announces 20 years of clinical trial software provision and hosting with zero downtime.

Encapsia is Cmed’s clinical data suite, designed around a unified clinical database with user-centric apps to support all trial processes and a full cloud architecture. The inherent flexibility of this structure means mid-study protocol amendments or technical system updates can be made with no disruption for users. In this respect, much of the knowledge and experience of Cmed’s previous technology platform, Timaeus, was applied to encapsia.

No downtime has significant benefits for trial sites, as they can enter data without interruption, avoiding one of the causes of data entry backlogs. The encapsia apps for EDC and direct data capture eSource are designed to be fast and user-friendly, even coping with intermittent internet access at sites. In combination, these features mean trial sites report a better experience with encapsia.

With no delays in data entry and all data held in a single unified database, sponsors benefit from live views of trial data that can be actioned within encapsia, for example, improving data monitoring and data review.

Dr. Timothy Corbett-Clark, Chief Technology Officer of Cmed, said, “We’re delighted to reach our latest milestone with no system downtime for our clients for 20 years.

“No Downtime means continuous, uninterrupted access by users, 24/7, regardless of database updates, trial configuration changes, or system upgrades. Nobody expects social media to go down for updates, so why not expect the same from modern EDC systems too?”

About Cmed and encapsia
Cmed Technology is the technology division of Cmed Group, with headquarters in Horsham, UK, plus offices in Morrisville, NC, Cambridge, MA, San Bruno, CA, Timisoara, Romania and Dublin, Ireland.

Cmed Technology is the developer of encapsia, an innovative, powerful, next-generation clinical data suite. Encapsia delivers a complete solution to gather and manage data in clinical trials with live insights and analytics on trial progress to inform and support management decisions. www.encapsia.com 

Contacts:
Ian Macholl, Marketing Manager
Cmed Group 
+44 1403 755 050 
e: imacholl@cmedgroup.com

Dr. Timothy Corbett-Clark, Chief Technology Officer
Cmed Group
+44 1403 755 050 
e: tcorbettclark@cmedtechnology.com

Related Images

cmed-logo.png
Cmed logo

Related Links

encapsia website

View original content to download multimedia:http://www.prnewswire.com/news-releases/cmed-reaches-20-years-of-zero-downtime-for-clinical-database-services-300972837.html

SOURCE Cmed Technology

Staff

Recent Posts

Therma Bright Inc. Announces Share Consolidation

Toronto, Ontario--(Newsfile Corp. - June 11, 2025) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF)…

11 minutes ago

FendX Engages Branding Expert to Support Branding and Marketing for Its Planned Eco-Friendly Sponge Products

Oakville, Ontario--(Newsfile Corp. - June 11, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF)…

1 hour ago

London College of Contemporary Arts Launches Free Mental Health and Wellness Support for Students and Staff

Global mental health and wellness solution leader Uwill accelerates international expansion with fifth UK partnership…

1 hour ago

P2P Group Increases Biometric Detection Range by 166%–Transforming Security, Defence and Aged Care

(CSE: PPB / FSE: 3QG / US: PPBGF)investor@p2p-group.com Highlights: Opens new markets in border control,…

1 hour ago

Strategikon Pharma Secures Growth Loan to Expand Sales and Client Support Teams Amid Rising Demand

Company-friendly debt solution will support expansion of the rapidly-growing innovative software company SAN FRANCISCO, June…

7 hours ago

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

SAN DIEGO, June 10, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), aligned with its commitments…

13 hours ago